BlackRock Institutional Trust Company, N.A. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$15,974,000
-42.1%
3,867,795
+13.5%
0.00%
-50.0%
Q3 2016$27,600,000
+17.1%
3,407,376
+12.8%
0.00%0.0%
Q2 2016$23,567,000
+5.8%
3,021,403
+4.7%
0.00%0.0%
Q1 2016$22,273,000
-29.2%
2,885,145
-1.1%
0.00%
-20.0%
Q4 2015$31,462,000
+61.1%
2,915,843
+3.2%
0.01%
+66.7%
Q3 2015$19,528,000
-18.9%
2,826,073
+4.0%
0.00%
-25.0%
Q2 2015$24,065,000
-15.1%
2,716,111
-5.5%
0.00%0.0%
Q1 2015$28,344,000
-8.6%
2,874,639
+13.6%
0.00%
-20.0%
Q4 2014$31,012,000
+19.1%
2,531,603
-3.0%
0.01%
+25.0%
Q3 2014$26,043,000
+12.2%
2,609,565
-14.9%
0.00%0.0%
Q2 2014$23,205,000
+124.0%
3,065,368
-2.6%
0.00%
+100.0%
Q1 2014$10,358,000
+4.4%
3,148,196
+5.3%
0.00%0.0%
Q4 2013$9,924,000
+21.5%
2,990,205
+10.5%
0.00%0.0%
Q3 2013$8,169,000
-58.5%
2,704,904
+12.4%
0.00%
-50.0%
Q2 2013$19,693,0002,407,4350.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders